|
||
Journal of Experimental Medicine, Vol 180, 2147-2153, Copyright © 1994 by Rockefeller University Press
ARTICLES |
M Pizza, MR Fontana, MM Giuliani, M Domenighini, C Magagnoli, V Giannelli, D Nucci, W Hol, R Manetti and R Rappuoli
Immunobiological Research Institute Siena (IRIS), Italy.
Escherichia coli enterotoxin (LT) and the homologous cholera toxin (CT) are A-B toxins that cause travelers' diarrhea and cholera, respectively. So far, experimental live and killed vaccines against these diseases have been developed using only the nontoxic B portion of these toxins. The enzymatically active A subunit has not been used because it is responsible for the toxicity and it is reported to induce a negligible titer of toxin neutralizing antibodies. We used site- directed mutagenesis to inactivate the ADP-ribosyltransferase activity of the A subunit and obtained nontoxic derivatives of LT that elicited a good titer of neutralizing antibodies recognizing the A subunit. These LT mutants and equivalent mutants of CT may be used to improve live and killed vaccines against cholera and enterotoxinogenic E. coli.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|